Valliance Asset Management Ltd Quant / Systematic

CIK: 0001846639 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Jan 31, 2024

Total Value ($000): $2,829 (100.0% shares, 0.0% debt)

Holdings (6)

NVDA NVIDIA CORPORATION 35.0%

Value ($000) $990 Shares 2,000 Est. Cost $44.77 Unrealized +3.4%

— YS BIOPHARMA CO LTD 29.0%

Value ($000) $821 Shares 1,607,175 Est. Cost $1.60 Unrealized —

MDB MONGODB INC 17.3%

Value ($000) $491 Shares 1,200 Est. Cost $379.37 Unrealized 0.0%

FIVN FIVE9 INC 17.2%

Value ($000) $488 Shares 6,200 Est. Cost $69.64 Unrealized 0.0%

LSBWF YS BIOPHARMA CO LTD 1.0%

Value ($000) $29 Shares 750,000 Est. Cost $0.16 Unrealized —

— HH&L ACQUISITION CO 0.4%

Value ($000) $10 Shares 400,000 Est. Cost $0.07 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
NVDA	NVIDIA CORPORATION	2,000	$990	35.0%	$44.77	+3.4%	COM	67066G104
—	YS BIOPHARMA CO LTD	1,607,175	$821	29.0%	$1.60	—	ORDINARY SHARES	G9845F109
MDB	MONGODB INC	1,200	$491	17.3%	$379.37	0.0%	CL A	60937P106
FIVN	FIVE9 INC	6,200	$488	17.2%	$69.64	0.0%	COM	338307101
LSBWF	YS BIOPHARMA CO LTD	750,000	$29	1.0%	$0.16	—	*W EXP 03/15/202	G9845F117
—	HH&L ACQUISITION CO	400,000	$10	0.4%	$0.07	—	*W EXP 02/04/202	G39714129